 | |
| Clinical data | |
|---|---|
| Trade names | Steranabol Depo, Steranabol Ritardo |
| Other names | Oxabolone cypionate; FI-5852; 4-Hydroxy-19-nortestosterone 17β-cypionate; Estr-4-en-4,17β-diol-3-one 17β-cypionate |
| Routes of administration | Intramuscular injection[1] |
| Drug class | Androgen;Anabolic steroid;Androgen ester |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| DrugBank |
|
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.013.647 |
| Chemical and physical data | |
| Formula | C26H38O4 |
| Molar mass | 414.586 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
 N Y (what is this?) (verify) | |
Oxabolone cipionate (INNTooltip International Nonproprietary Name,JANTooltip Japanese Accepted Name) (brand namesSteranabol Depo,Steranabol Ritardo; former developmental code nameFI-5852), oroxabolone cypionate, also known as4-hydroxy-19-nortestosterone 17β-cypionate orestr-4-en-4,17β-diol-3-one 17β-cypionate, issynthetic andinjectedanabolic–androgenic steroid (AAS) andderivative ofnandrolone (19-nortestosterone) which has been marketed inEurope.[1][2][3] It is the C17βcypionateester and aprodrug ofoxabolone (4-hydroxy-19-nortestosterone).[2][3]
 | Thisdrug article relating to thegastrointestinal system is astub. You can help Wikipedia byexpanding it. |